Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Status:
Not yet recruiting
Trial end date:
2027-09-07
Target enrollment:
Participant gender:
Summary
This study is a mechanistic randomized controlled trial that investigates whether inhibition
of tumor necrosis factor signaling via intravenous infusion of infliximab improves
psychomotor speed and executive functioning in depressed individuals who exhibit an
inflammatory phenotype.